These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10775813

  • 1. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection.
    Yamani MH, Starling RC, Pelegrin D, Platt L, Majercik M, Hobbs RE, McCarthy P, Young JB.
    J Heart Lung Transplant; 2000 Apr; 19(4):337-42. PubMed ID: 10775813
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
    Meiser BM, Uberfuhr P, Fuchs A, Schulze C, Nollert G, Mair H, Martin S, Pfeiffer M, Reichenspurner H, Kreuzer E, Reichart B.
    J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 6. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
    Rostaing L, Chabannier MH, Modesto A, Rouzaud A, Cisterne JM, Tkaczuk J, Durand D.
    Am J Nephrol; 1999 Aug; 19(6):634-40. PubMed ID: 10592356
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation.
    Eberhard OK, Kliem V, Oldhafer K, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R.
    Transplantation; 1996 May 15; 61(9):1345-9. PubMed ID: 8629294
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy and safety of conversion to tacrolimus in heart transplant recipients with ongoing or recurrent acute cellular rejection.
    Skalická B, Málek I, Kubánek M, Vymětalová J, Kautzner J.
    Physiol Res; 2010 May 15; 59(3):379-384. PubMed ID: 19681656
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
    Millis JM, Woodle ES, Piper JB, Bruce DS, Newell KA, Seaman DS, Baker AL, Hart J, Dasgupta K, Thistlethwaite JR.
    Transplantation; 1996 May 15; 61(9):1365-9. PubMed ID: 8629298
    [Abstract] [Full Text] [Related]

  • 14. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    Taylor DO, Barr ML, Radovancevic B, Renlund DG, Mentzer RM, Smart FW, Tolman DE, Frazier OH, Young JB, VanVeldhuisen P.
    J Heart Lung Transplant; 1999 Apr 15; 18(4):336-45. PubMed ID: 10226898
    [Abstract] [Full Text] [Related]

  • 15. OKT3 for the treatment of steroid-resistant acute renal allograft rejection.
    Jogose JT, Bailey RR, Lynn KL, Robson RA, Wells JE.
    Nephron; 1997 Apr 15; 77(3):298-303. PubMed ID: 9375823
    [Abstract] [Full Text] [Related]

  • 16. Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection.
    Midtvedt K, Tafjord AB, Hartmann A, Eide TC, Holdaas H, Nordal KP, Draganov B, Sødal G, Leivestad T, Fauchald P.
    Transplantation; 1996 Jul 15; 62(1):38-42. PubMed ID: 8693541
    [Abstract] [Full Text] [Related]

  • 17. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M, Lake KD, Pritzker MR, Jorgensen CR, Arom KV, Love KR, Emery RW.
    J Heart Lung Transplant; 1991 Jul 15; 10(6):901-11. PubMed ID: 1661608
    [Abstract] [Full Text] [Related]

  • 18. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection.
    Herget S, Heemann U, Friedrich J, Kribben A, Wagner K, Philipp T.
    Clin Nephrol; 1996 May 15; 45(5):352-4. PubMed ID: 8738671
    [Abstract] [Full Text] [Related]

  • 19. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.
    J Pediatr Surg; 1997 May 15; 32(5):688-90. PubMed ID: 9165452
    [Abstract] [Full Text] [Related]

  • 20. OKT3 rescue for steroid-resistant rejection in adult liver transplantation.
    Solomon H, Gonwa TA, Mor E, Holman MJ, Gibbs J, Watemberg I, Netto G, Goldstein RM, Husberg BS, Klintmalm GB.
    Transplantation; 1993 Jan 15; 55(1):87-91. PubMed ID: 8420070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.